Matinas BioPharma Holdings MTNB
NYSE MTNB
$2.55 -0.28 (-9.89%)
At close: Sep 30, 2026 · 4:00 PM EDT

Matinas BioPharma Holdings (MTNB) Change in Receivables (2015 - 2017)

Updated

Matinas BioPharma Holdings' Change in Receivables was -$5.00 in Q3 2017.

Analysis

Matinas BioPharma Holdings (MTNB) Change in Receivables (2015 - 2017) Analysis & Trends

  • The Q3 2017 figure marks the lowest quarterly Change in Receivables since Q1 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.35 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.37 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.09 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 333.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 140.20 Mn
10 Matinas BioPharma Holdings 16.34 Mn 3.74 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 -5.00
Mar 31, 2015 -15,535.00
API Access

Matinas BioPharma Holdings Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=MTNB&period=max&api_key=YOUR_API_KEY